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Abstract
Wharton’s jelly stem cells (WJSCs) are a potential source of transplantable stem cells in cartilage-
regenerative strategies, due to their highly proliferative and multilineage differentiation capacity.
We hypothesized that a non-direct co-culture system with human articular chondrocytes (hACs)
could enhance the potential chondrogenic phenotype of hWJSCs during the expansion phase
compared to those expanded in monoculture conditions. Primary hWJSCs were cultured in the
bottom of a multiwell plate separated by a porous transwell membrane insert seeded with hACs.
No statistically signiﬁcant differences in hWJSCs duplication number were observed under either of
the culture conditions during the expansion phase. hWJSCs under co-culture conditions show
upregulations of collagen type I and II, COMP, TGFβ1 and aggrecan, as well as of the main cartilage
transcription factor, SOX9, when compared to those cultured in the absence of chondrocytes.
Chondrogenic differentiation of hWJSCs, previously expanded in co-culture and monoculture
conditions, was evaluated for each cellular passage using the micromass culture model. Cells
expanded in co-culture showed higher accumulation of glycosaminoglycans (GAGs) compared to cells
in monoculture, and immunohistochemistry for localization of collagen type I revealed a strong
detection signal when hWJSCs were expanded under monoculture conditions. In contrast, type II
collagen was detected when cells were expanded under co-culture conditions, where numerous
round-shaped cell clusterswere observed. Using amicromass differentiationmodel, hWJSCs, previously
exposed to soluble factors secreted by hACs, were able to express higher levels of chondrogenic genes
with deposition of cartilage extracellular matrix components, suggesting their use as an alternative cell
source for treating degenerated cartilage. Copyright © 2015 John Wiley & Sons, Ltd.
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1. Introduction
Cartilage is an avascular musculoskeletal tissue with a low
capacity for self-repair. Damage by trauma or disease re-
sults in the loss of partial or complete tissue functionality.
During the past 15 years, several clinical approaches, such
as microfracture, arthroscopy and laser abrasion, have
been performed for partially restoring function to patho-
logically altered cartilage (Hunziker, 2002; Risbud and
Sittinger, 2002; Cancedda et al., 2003; Mano and Reis,
2007). The autologous chondrocyte implantation (ACI)
technique, proposed by Brittberg et al. (1994), is a clear
example of a cell-based therapy with excellent clinical re-
sults. The use of ACI is associated with a number of limi-
tations, such as morbidity of the surgical procedure,
frequent occurrence of periosteal hypertrophy and inefﬁ-
cient cell retention. In addition, it involves lengthy and
costly cell isolation and expansion steps of human
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articular chondrocytes (hACs), which have low cellular
mitosis and are prone to dedifferentiation when expanded
in two dimensions (2D). A potential improvement in ACI
procedure is the application of mesenchymal stem cells
(MSCs) (Tuan, 2006) instead of hACs in order to mini-
mize additional donor site morbidity. MSCs are attractive
candidates for cartilage cell-based therapies because they
have the potential to differentiate into the chondrogenic
lineage when supplemented with proper differentiation
signals (Johnstone et al., 1998; Pittenger et al., 1999;
Tuan, 2006; Hwang et al., 2007). Adult stem cells present
a limited degree of proliferation, with maintenance of
their multipotency capacity of differentiation. Recently,
fetal stem cells have attracted increased interest due to
their unique features, such as a high capacity to prolifer-
ate, maintenance of the self-renewal potential over time
and the ability to differentiate towards almost all cell
types (Jo et al., 2008; Marcus and Woodbury, 2008).
These cells are derived from supportive extra-embryonic
structures of fetal origin, such as umbilical cord blood,
Wharton’s jelly, amniotic ﬂuid, amniotic membrane and
placenta, which are routinely discarded after birth. Being
extra-embryonic fetal tissues with a large mass volume,
these tissues are suitable sources for stem cell isolation.
In particular, stem cells derived from the human umbilical
cord outer region, known as Wharton’s jelly stem cells
(WJSCs), have been isolated from the mucoid connective
tissue that surrounds the two arteries and the single vein
of the umbilical cord. These cells retain many embryonic
stem cells (ESCs) and MSC markers in primary cultures
at early passages and can be expanded without signiﬁcant
loss of stemness for at least 50 passages (Jo et al., 2008).
Recently, various authors have shown that WJSCs present
several advantages compared to adult MSCs, such as
higher frequency of colony-forming-unit ﬁbroblasts
(CFU-Fs) and shorter population doubling time, both crit-
ical for scaling-up stem cell cultures (Lu et al., 2006).
WJSCs can differentiate into adipogenic, osteogenic,
chondrogenic and cardiomyogenic lineages (Wang et al.,
2004) and dopaminergic neurons (Fu et al., 2006; Weiss
et al., 2006). These cells also express some pluripotent
stem cell markers, including Oct-4, Sox-2 and Nanog in
cells of porcine origin (Carlin et al., 2006), Oct-4, SSEA-
4 and c-Kit in cells from equine sources (Hoynowski
et al., 2007) and SSEA-1, SSEA-4, Tra-1–60 and Tra-1–
81 in cells from human sources (Jo et al., 2008), suggest-
ing a more immature state than adult MSCs.
Controlling cell differentiation is one of the most chal-
lenging aspects of cell-based regenerative therapies, since
the mechanisms by which stem cells differentiate can be
difﬁcult to recapitulate with current technologies. Co-
culture systems with relevant cells can be used as valuable
tools for probing and manipulating the molecular mecha-
nisms by which stem cells differentiate and could offer
therapeutic possibilities in cartilage regeneration strate-
gies. Previously, chondrocytes have been shown to secrete
various soluble morphogenic factors able to promote the
chondrogenic differentiation of MSCs (Hwang et al.,
2007). In this study, we hypothesized that factors secreted
by chondrocytes possess chondrogenic-differentiating ef-
fects and could enhance chondrogenesis of human
Wharton’s jelly stem cells (hWJSCs) when co-cultured
with human articular chondrocytes (hACs). Particularly,
we investigated: (a) whether chondrocytes cultured in a
Transwell system could inﬂuence the proliferation ratio
of hWJSCs during expansion (as illustrated in Figure 1);
(b) the relative gene expression of hWJSCs in the presence
or absence of hACs; (c) the effect of non-direct co-culture
on the ability of hWJSCs to differentiate into the
chondrogenic lineage, using the micromass culture model.
Previous work has shown that hWJSCs cultured in
three-dimensional (3D) scaffolds in the conditioned me-
dium of hACs cultures presented higher expression of
aggregan, SOX9 and collagen type II than those cultured
in the absence of hACs medium (Alves da Silva et al.,
2015). However, to the best of our knowledge, the effect
of non-direct co-culture with hACs on the ability of
hWJSCs to undergo chondrogenic differentiation in
micromass pellets has not been reported. We believe that
considerable efforts will be directed to this area of re-
search, since WJSCs are a potential cell source for muscu-
loskeletal tissue engineering.
2. Materials and methods
2.1. Isolation of hWJSCs and hACs
Human umbilical cords were collected from mothers who
underwent full-term pregnancy, after their consent and
approval from the São Marcos Hospital (Braga, Portugal)
Ethics Committee.
Brieﬂy, the cord was sectioned into four pieces and the
blood vessels were separated from the Wharton’s jelly.
The collected vessels were washed in phosphate-buffered
saline (PBS; pH 7.4, Invitrogen, UK) solution and loops
were created with sutures. The vessels were incubated in
a 0.50 mg/ml collagenase type I (Sigma, St. Louis, MO,
USA) solution for 18 h at 37°C under slow agitation. After
incubation, the digested vessels were diluted with PBS.
The solution was collected and centrifuged for 10 min at
1150 rpm. This step was repeated until the solution vis-
cosity was reduced. The vessels were discarded and the
cell suspension was incubated with erythrocyte lysis
buffer and incubated for 5 min at room temperature
(RT). The cell suspension was centrifuged and the ob-
tained cell pellet dissolved in culture medium. The cells
were counted and plated onto a culture ﬂask.
Bioptic material for articular chondrocyte isolation was
collected from the femoral condyles of patients undergo-
ing partial knee arthroplasty (three female patients, me-
dian age 73 years). All patients signed an informed
consent approved by the Ethical Committee of São Marcos
Hospital.
Articular cartilage was cleaned of connective tissue and
subchondral bone, minced into small fragments and rinsed
in fresh PBS, pH 7.4, according to previously published
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procedures (Pereira et al., 2009). The chondrocytes were
individually released by consecutive enzymatic digestion;
400 U/ml collagenase I, 1000 U/ml collagenase II
(Worthing Biochemical, Lakewood, NJ, USA), 0.25%
trypsin (Invitrogen, UK), 1 mg/ml hyaluronidase (Sigma,
USA) in Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Sigma-Aldrich, Germany) with phenol red at 37°C.
2.2. Co-culture of hWJSCs with hACs
For co-culturing hWJSCs with hACs, a transwell sys-
tem (Corning Inc., Transwell®) was used where
hACs, at a cell density of 18 000 cells/cm2, were
plated in the Transwell chambers and placed above
the hWJSCs layer, plated at a density of 15 000
cells/cm2. Cells share the same medium, but no direct
cell-cell contact is allowed, due to the physical separa-
tion of the cells by a polycarbonate membrane with
pore size 0.4 μm, which does not allow cell migration
through the membrane (Figure 1B). Cells were
cultured in α-medium (Sigma, USA) supplemented
with 10% fetal bovine serum (FBS; Biochrom AG,
Germany), 5 mM L-glutamine (Sigma, St. Louis, MO,
USA) and 1% antibiotic–antimicotic mixture
(Invitrogen). hACs plated in the inserts were
replenished at each enzymatic detachment of hWJSCs
at P1. Chondrocytes on the Transwell inserts were
trypsinized and processed for cell imaging, staining
and PCR (see below, section 2.3.4).
2.3. Characterization of
chondrogenic-stimulated hWJSCs
2.3.1. Growth kinetics
The growth rate (number of cell doublings) of hWJSCs, cul-
tured in the presence or absence of chondrocytes, was calcu-
lated with respect to their starting number plated at each
passage, 1.5 × 104 cells/cm2 in the six multiwell tissue-
culture plates. Number of duplications was plotted vs time
to show the effect of culture conditions on cell proliferation.
The cells were successively passaged using trypsin–EDTA
(Invitrogen Life Technologies, Carlsbad, CA, USA), counted
with trypan blue (Invitrogen, UK) staining using a
Newbauer chamber. Each time point was assessed (n = 3).
2.3.2. Cell morphology
hWJSCs cultured on six-well cell-culture plates were
observed during the course of culture, using a brightﬁeldmi-
croscope (AXIOVERT 40 CFL, Germany) equipped with a
digital camera (Canon Power Shot G8, Japan). Images at dif-
ferent passages were acquired at×5 and×10magniﬁcation.
2.3.3. Expression of surface markers – ﬂow
cytometry
The phenotype of hWJSCs cultured on polystyrene tissue
culture plates (monoculture) and in co-culture with hACs
in multiwell inserts was assessed by ﬂow cytometry. Brieﬂy,
harvested cells were incubated with ﬂuorescent monoclonal
Figure 1. (A) Environmental factors affecting cell behaviour (adapted from Lutolf and Hubbell, 2005). Cells receive multiple signals
from their surroundings including neighboring cells. In this study, we investigated whether chondrocyte-secreted morphogenic fac-
tors can stimulate the chondrogenic commitment of human Wharton’s jelly stem cells (hWJSCs). (B) Experimental design and sche-
matic representation of the culture conditions used in this study
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antibodies against CD105 (AbD Serotec, UK), CD44 and
CD90 (BD Biosciences Pharmingen, USA) for 15 min at
room temperature (RT). The cells were then washed in
PBSwith 1% sodium azide (Sigma) and ﬁxedwith 2% form-
aldehyde. Unlabelled controls were included in every exper-
iment to evaluate non-speciﬁc binding. The samples were
analysed using a FACScalibur with CellQuest analysis soft-
ware (both Becton-Dickinson, USA).
2.3.4. Gene expression – RNA extraction and
quantitative reverse transcriptase polymerase
chain reaction (qRT–PCR)
hWJCs co-cultured with hACs and in monoculture condi-
tions were collected at each passage, washed in PBS,
immersed in Trizol® reagent (Invitrogen) and kept at
!80°C for subsequent RNA extraction (Pereira et al.,
2009). Brieﬂy, the cells were incubated at 4°C for
10 min with chloroform (Sigma) and then centrifuged at
13 000 rpm for 15 min; 700 μl supernatant were collected
and an equivalent volume of isopropanol (Sigma/I-9516)
was added. After RNA precipitation (which occurred
within 1 h), the samples were centrifuged at 13 000 rpm
and 4°C for 15 min. The supernatant was removed and
700 μl 70% ethanol was added. The Eppendorf tubes
were again centrifuged at 13 000 rpm at 4°C for 5 min,
and the supernatant was removed. The pellet was left to
air-dry at RT and at the end was resuspended in 50 μl
DNase/RNase-free distilled water (Gibco/10977-015).
RNA content and integrity was assessed using a ND-1000
spectrophotometer (NanoDrop Technologies, USA). Iso-
lated RNA was transcribed into cDNA using the iScript
cDNA synthesis kit (1708891). Relative gene expression
quantiﬁcation was performed by quantitative real-time
RT–PCR (qPCR) using a BioRad CFX96 real-time PCR de-
tection system (BioRad Laboratories, CA, USA) and SYBR
Green IQ Supermix (Bio-Rad Laboratories). Primer Ex-
press software was used to generate the forward and re-
verse oligonucleotides listed in Table 1. cDNA (2 μl in a
total volume of 25 ml/reaction) was analysed for the gene
of interest and for the reference gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). The expression level
of each target gene was calculated using the –2ΔΔCT
method, as described by Livak and Schmittgen (2001).
Each sample was analysed three times for the gene of
interest.
2.4. Chondrogenic differentiation of hWJSCs
2.4.1. Micromass pellet culture
The chondrogenic differentiation capacity of hWJSCs,
previously exposed to soluble factors secreted by
chondrocytes during cell expansion, was investigated
using a 3D high-density cell micromass culture model, as
described by Johnstone et al. (1998). Brieﬂy, at each pas-
sage, cells were trypsinized and 2.5 × 105 cell aliquots
were collected in 15 ml conical tubes (Sarstedt,
Numbrecht, Germany). The cells were suspended in
chondrogenic medium, consisting of serum-free DMEM
supplemented with insulin–transferrin–selenium (ITS + 1;
Sigma, St. Louis, MO, USA), 10 ng/ml transforming growth
factor (TGF)β1, 100 nM dexamathasone, 50 μg/ml ascorbic
acid, 2 mM L-glutamine, 40 μg/ml L-proline and 1 mM
sodium pyruvate. The suspended cells were centrifuged for
2min at 1400 rpm to allow the formation of spherical pellets.
The pellets (n = 3) were cultured in chondrogenic medium
for 3 weeks with medium changes every 2 days, and subse-
quently processed for histological and immunohistochemical
analysis.
2.4.2. Deposition of cartilage extracellular matrix
(ECM) – histology and immunohistochemistry
For histological and immunohistochemical analyses, pel-
lets were ﬁxed in 10% neutral buffered formalin (forma-
lin, Sigma), washed twice in PBS for 15 min, dehydrated
in a graded series of ethanols and then embedded in par-
afﬁn. Cross-sections (4 μm thickness) were cut, dewaxed
and stained with safranin O for detection of sulphated gly-
cosaminoglycan (sGAG). Brieﬂy, the slides were ﬁrst
washed in running tap water, quickly destained with fresh
acid ethanol (1% hydrochloric acid in 70% ethanol),
again washed in running tap water and then immersed
in 1:500 fast green (Fluka, cat. no. 44715) for 3 min, after
which they were immersed in 1% acetic acid (Panreac,
cat. no. 131008) solution for 30 s and immersed in 0.1%
safranin O (Fluka, cat. no. 84120) for 4 min. The slides
were washed in running tap water, counterstained with
haematoxylin, cleared in xylene and mounted. Inserts
containing human articular chondrocytes were also proc-
essed for safranin O staining. They were washed twice
with PBS, ﬁxed in formalin and stained for GAG detection.
Table 1. Primers used to evaluate gene expression of hWJSCs by qRT–PCR
Gene Forward Reverse
GAPDH 5′-ACAGTCAGCCGCATCTTCTT-3′ 5′-ACGACCCAAATCCGTTGACTC-3′
Collagen type I 5′-CATCTCCCCTTCGTTTTTGA-3′ 5′-CCAAATCCGATGTTTCTGCT-3′
Collagen type II 5′-GACAATCTGGCTCCCAAC-3′ 5′-ACAGTCTTGCCCCACTTAC-3′
Collagen type X 5′-CCAGGTCTCGATGGTCCTAA-3′ 5′-GTCCTCCAACTCCAGGATCA-3′
Sex-determining region Y box 9 (SOX9) 5′-TACGACTACACCGACCACCA-3′ 5′-TTAGGATCATCTCGGCCATC-3′
Cartilage matrix oligomeric protein (COMP) 5′-CCCACAGACCCTTCCAAGTA-3′ 5′-GGGGACAACTGGAGTGAAAA-3′
Transforming growth factor-β (TGFβ) 5′-CTCCTCGGAAGACACTCTG-3′ 5′-AGACTGCGCCTGGTAGTTG-3′
Aggrecan 5′-TGAGTCCtTCAAGCCTCCTGT-3′ 5′-TGGTCTGCAGCAGTTGATTC-3′
Runt-related transcription factor 2 (Runx2) 5′-TTCCAGACCAGCAGCACTC-3′ 5′-CAGCGTCAACACCATCATTC-3′
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For immunohistochemistry examination, slides were
dewaxed, washed with PBS solution and the exogenous
peroxidase activity quenched with 0.6% hydrogen perox-
ide in methanol for 10 min and blocked with RTU
Vectastain® normal horse serum [Vectastain® Universal
Elite ABC Kit (Vector, cat. no. VCPK-7200)] for 20 min.
The slides were then incubated with rabbit anti-collagen
types I (1:200) and II (1:75) primary antibodies (Abcam,
Cambridge, MA, USA) overnight at 4°C in a humidiﬁed at-
mosphere. A secondary antibody (Vectastain ABC Kit) was
applied for 1 h at RT in a humidiﬁed atmosphere,
followed by the avidin–biotinylated enzyme complex
(Vectastain ABC Kit) and DAB reagent (Vector Laborato-
ries, cat. no. VCSK-4100), then the slides were counter-
stained with haematoxylin and mounted. Slides stained
without the addition of the primary antibody served as
negative controls. Native human articular cartilage was
used as a positive control for collagens type I and II.
2.5. Statistical analysis
The number of cell duplications and relative gene expres-
sion quantiﬁcations are expressed as mean ± standard de-
viation (SD), with n = 3 for each culture condition. The
statistical signiﬁcance of differences was determined
using Student’s t-test multiple comparison procedure at
a conﬁdence level of 95% (p < 0.05).
3. Results
3.1. Characterization of hACs during co-culture
During the co-culture experiments, chondrocytes were
seeded on Transwell inserts and stained at each cellular
passage with Alcian blue,Toluidine blue or safranin O to
detect the presence of cartilage glycosaminoglycans
(GAGs). Multiwell inserts without chondrocytes were also
stained and used as controls, to conﬁrm the absence of
possible staining artifacts. Membrane inserts did not col-
our when cells were not present (data not shown). On
the contrary, hACs cultured for 1 week were positive for
the presence of GAGs (Figure 2A). Imaging of hACs dur-
ing in vitro co-culture showed that the cells maintained
their characteristic polygonal morphology with full colo-
nization of the surface (Figure 2B). The levels of several
transcripts of chondrocytes were assessed by means of
PCR analysis. Ampliﬁed products were resolved on 1%
agarose gels (Figure 2C). Collagen types I and II and
aggrecan were present in small amounts. Cartilage-
speciﬁc transcription factors SOX9, COMP and TGFβ1
genes were also detected. These results indicate that hACs
were able to maintain their inherent chondrogenic
phenotype.
3.2. Characterization of
chondrogenic-stimulated hWJSCs
Calculation of the duplication number vs time during
the total period of culture allowed assessment of the
proliferation capacity of hWJSCs, either in co-culture
with chondrocytes or in monoculture (Figure 3A). Cellu-
lar duplication was constant for the whole culture time.
Similar duplication number values were observed for
both culture conditions, with no statistically signiﬁcant
differences. Possible changes in cell morphology during
expansion were also monitored (Figure 3B). Either un-
der monoculture or co-culture conditions, hWJSCs main-
tained their characteristic long-shape morphology and
colonized the entire plastic surface over the time of
Figure 2. Characterization of human articular chondrocytes (hACs) after 1week in co-culture with hWJSCs. (A) Toluidine blue, Alcian blue
and safraninO staining (from top to bottom) of hACs cultured onmultiwell inserts. (B) Lightmicroscopy images showing chondrocytemor-
phology in 2D culture; scale bar = 100 μm; (C) Real-time RT–PCR analysis of chondrogenic marker genes conﬁrming that chondrocytes
maintain their phenotype during the culture time. DNA fragments and products of real-time RT–PCR for each gene were set in agarose gel
Chondrogenic commitment of human Wharton’s jelly stem cells
Copyright © 2015 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2015)
DOI: 10.1002/term
culture. Analysis of speciﬁc clusters of differentiation
(CD) on the surface of hWJSCs during its expansion, un-
der both culture conditions, was assessed by ﬂow cytom-
etry (Figure 3C). Cultured cells were analysed for the
presence of mesenchymal stem cell markers (CD44,
CD73 and CD105), expression of which was > 95%
and no differences were observed for the different cell
passages.
3.3. Expression proﬁle of chondrocyte–speciﬁc
genes by hWJSCs
To assess variations in gene expression by hWJSCs, either
in co-culture or in monoculture, qPCR was performed to
quantify the expression proﬁle of several genes by these
cells during the expansion phase; GAPDH was chosen as
the reference housekeeping gene. Relative gene expres-
sion was quantiﬁed by normalizing gene values with those
expressed by hWJSCs in monoculture (Figure 4). We ob-
served an upregulation of gene expression for all analysed
genes when hWJSCs were co-cultured with chondrocytes.
Collagen type I presented the highest relative expression,
four-fold at passage 3. With further passages during cell
expansion, the level of collagen type I expression pre-
sented a continuous decrease of fold induction. The oppo-
site tendency of fold expression could be observed for
type II collagen, which augmented with cell expansion.
A drastic reduction of aggrecan expression level was ob-
served from P3 to P4 but then increased until P6. A slight
reduction of Sox9 relative expression was observed with
cellular passage. Upregulation of TGFβ1 was observed
for hWJSCs co-cultured with chondrocytes compared to
those expanded alone. Relative induction fold values of
this gene increased gradually during culture. Cartilage
oligomeric matrix protein (COMP) relative expression
values tended to increase, especially for the latest stages
of cell expansion; this tendency was mainly observed in
the ﬁrst three cell passages. Type X collagen (a hypertro-
phic chondrocyte marker) and Runx2 (pre-osteogenic
gene marker) relative expression values showed analo-
gous behaviour. A decrease in the ﬁrst two passages was
observed, with further low expression until the sixth
passage.
Figure 3. Characterization of chondrogenic-stimulated hWJSCs. (A) Doubling numbers during the expansion phase: growth kinetics
plotted as number of cell duplications vs time of culture (proliferation); solid line, hWJSCs co-cultured with hACs; dashed line,
hWJSCs in monoculture. (B) Optical microscopy images of hWJSCs in monoculture and co-culture conditions during the expansion
phase at passages (P) P4, P5 and P6; scale bar = 100 μm. (C) Flow-cytometry analysis of CD105, CD73 and CD44 expression on
hWJSCs at different passages after co-culture with hACs and in monoculture conditions
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3.4. Chondrogenic differentiation of hWJSCs in
micromass pellet culture model
3.4.1. Deposition of glycosaminoglycans
Histological analysis of micromass pellets of hWJSCs, pre-
viously expanded under co-culture and monoculture con-
ditions, was performed using safranin O staining, which
detects cartilage glycosaminoglycans (Figure 5). This
analysis showed a non-homogeneous distribution of the
cells within micromass pellets. The pellets displayed posi-
tive staining for safranin O at each cellular passage for
both culture conditions. Despite this positive staining,
hWJSCs cultured in the absence of chondrocytes pre-
sented a more ﬁbroblast-like morphology than those ex-
panded in co-culture.
3.4.2. Deposition of collagen types I and II
The results from immunohistochemical localization of col-
lagen types I and II can be appreciated in Figure 6. A more
positive staining of type I collagen was detected in the
micromass pellets obtained with cells expanded in mono-
culture than those expanded in co-culture (Figure 6). A
signiﬁcant detection of collagen type II in pellets formed
with co-cultured hWJSCs was observed.
4. Discussion
One of the difﬁculties of engineering and repairing carti-
lage is the lack of a sufﬁcient number of cells when using
autologous chondrocytes. In recent years, this ﬁeld of re-
search has shown an increasing interest in using alterna-
tive cell sources and a valid culture systems (Sekiya
et al., 2002; Tuan, 2006).
Mesenchymal stem cells (MSCs) found in several tis-
sues, such as bone marrow (Bianco et al., 2001), adipose
tissue (Zuk et al., 2002) and umbilical cord (Troyer and
Weiss, 2008), have demonstrated a multilineage potential
and have been considered a potential alternative to autol-
ogous chondrocytes. Barry et al. (2001) showed the
chondrogenic differentiation ability of MSCs from bone
marrow with the potential risk of hypertrophy induction.
Currently, adipose stem cells are an abundant source of
adult stem cells, but their chondrogenic potential is
known to be inferior to those from bone marrow (Huang
et al., 2005).
Like human umbilical cord stem cells (Bailey et al.,
2007; Wang and Detamore, 2009; Wang et al., 2009a,
2009b), we suggest that hWJSCs could be a useful cell
source for cartilage regeneration strategies. This cell type
combines most of the ESC and adult MSCs ’stemness’
markers for long expansion periods (Jo et al., 2008),
showing the ability to differentiate along mesenchymal
lineages (Wang et al., 2004; Can and Karahuseyinoglu,
2007). Harvested from umbilical cords, hWJSCs are easily
accessible, presenting high levels of proliferation during
in vitro expansion and making it possible to obtain a plen-
tiful amount of cells in a short period of time (Baksh et al.,
2007; Can and Karahuseyinoglu, 2007).
Cartilage tissue engineering success depends not only
on biomaterial selection, but also on the development of
efﬁcient approaches to control cell differentiation and
neo-tissue assembly. In this perspective, chondrocytes
have been employed in several studies using co-culture
systems, with direct or non-direct cell contact, to achieve
either chondrogenic or osteogenic differentiation of mes-
enchymal stem cells (Gerstenfeld et al., 2002, 2003;
Hwang et al., 2007).
The use of hACs in a non-direct co-culture system with
hWJSCs (Alves da Silva et al., 2015) has not been fully
explored, and the increased interest in this cell type in
cartilage tissue engineering led us to propose this study.
Co-culture of hWJSCs with hACs using α-medium supple-
mented with 10% FBS for almost 36 days did not show
statistically signiﬁcant differences in the proliferation
Figure 4. Expression proﬁle of chondrocyte-speciﬁc genes (A–E), collagen type I (F), collagen type X (G) and Runx2 (H) by hWJSCs
during the expansion phase at different passages. Level of mRNA transcripts fold induction of hWJSCs co-cultured with chondrocytes
was normalized to values achieved form hWJSCs cultured alone during the expansion phase. Statistical analysis was performed
through the various passages (p < 0.05)
Chondrogenic commitment of human Wharton’s jelly stem cells
Copyright © 2015 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2015)
DOI: 10.1002/term
ratio, compared to those cultured under the same condi-
tions but in the absence of chondrocytes (Figure 3). This
result was not in agreement with data found in previous
studies, where soluble factors released from chondrocytes
enhanced the survival and proliferation of mesenchymal
cells (Solursh, 1975; Hwang et al., 2007, 2008), but none
of these studies used hWJSCs. Under both conditions,
hWJSCs achieved ca. 20 duplications (corresponding to
a 64-fold increase of the initial cell number) in about 36
days of culture. It is well known that chondrocytes ex-
panded ex vivo undergo phenotype changes, with the dif-
ferent expression of several chondrogenic gene markers
depending on expansion time (von der Mark et al.,
1977; Malpeli et al., 2004). For this reason, each time
hWJSCs were counted and replated in the polystyrene
culture plates, on average every 8 days, hACs were also
detached by enzymatic digestion with trypsin. Fresh hACs
at P1 were replated in the insert wells. This was per-
formed to avoid further expansion of hACs and thus pre-
vent their possible dedifferentiation (Malpeli et al.,
2004). As shown in Figure 2A, hACs seeded on Transwell
inserts were macroscopically positive for Alcian blue, tolu-
idine blue and safranin O staining, demonstrating their
ability to accumulate cartilage GAGs. The low level of col-
lagen type I expression indicated a low cell proliferation
ratio, characteristic of the chondrogenic phenotype
(Malpeli et al., 2004). When plated in monolayer (2D sur-
faces), chondrocytes hardly preserved the expression of
Figure 5. Histological staining of 3Dmicromass pellet cross-sections of hWJSCs after being expanded in monoculture (A) or in co-cul-
ture with hACs (B), stained with safranin O, which detects the presence of sulphated glycosaminoglycans; scale bar = 100 μm
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Figure 6. Immunohistochemical detection of collagen types I and II in micromass pellets of hWJSCs after expansion in monoculture
(A) and in co-culture with hACs (B); scale bar = 100 μm
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collagen type II (Malpeli et al., 2004). This behaviour was
also observed in our study, conﬁrmed by the faint line ob-
served for the ampliﬁed DNA fragment. Nevertheless, we
observed that hACs at P1 were able to express other typi-
cal cartilage marker genes, such as aggrecan, COMP and
TGFβ1, as well as the cartilage master transcription factor
SOX9, an important protein implicated in the mainte-
nance of the chondrogenic phenotype in articular
chondrocytes (Malpeli et al., 2004). Based on these re-
sults, we assumed that human articular chondrocytes
plated in the multi-well inserts maintained the majority
of their chondrogenic phenotype characteristics.
The deﬁning characteristics of MSCs include their abil-
ity to self-renew and to express speciﬁc markers, such as
CD73, CD90 and CD105, on their surface (Delorme et al.,
2008; Jin et al., 2009). CD105, a 180 kDa integral mem-
brane glycoprotein known as endoglin, is a receptor for
TGFβ1 and TGFβ3 and modulates TGFβ signalling by
interacting with related molecules, such as TGFβ1,
TGFβ3, BMP-2 and BMP-7. It is speculated that these
members of the TFGβ superfamily are mediators of cell
proliferation and differentiation and play regulatory roles
in cartilage and bone formation. The disappearance of
CD105 antigen during osteogenesis suggests that this pro-
tein, like others in the TFGβ superfamily, may be involved
in the regulation of osteogenesis. Recent studies reported
that members of the TGFβ family control the differentia-
tion of MSCs (Haynesworth et al., 1992; Jakob et al.,
2001). However, whether CD105 plays a functional role
during the process of stem cell differentiation has not
yet been clariﬁed. Therefore, we evaluated the potential
effect of chondrocyte soluble factors over the expression
proﬁle of MSCs markers (CD44, CD73 and CD105) on
hWJSCs co-cultured with hACs for several passages (Fig-
ure 3C). No signiﬁcant differences were observed at the
phenotypic level under co-culture conditions.
Cartilage master transcription factor SOX9 (Lefebvre
et al., 1998; Sekiya et al., 2002; Malpeli et al., 2004)
(Figure 4), was upregulated in hWJSCs in co-culture con-
ditions relative to those cultured alone, presenting at P3
and P4 the highest values of relative fold induction, 2.4
and 2.2, respectively. With further cell expansion, a minor
decrease of relative fold until P6 was observed. Relative
fold induction values of TGFβ1 gradually increased from
P3 up to P5 (0.9–1.2), presenting a plane behaviour for
the next passage (1.1-fold). Cartilage oligomeric matrix
protein (COMP) has an important role in cartilage pheno-
type maintenance (Zaucke et al., 2001). COMP relative ex-
pression shows a slow increase from P3 to P4 (0.2–0.4 in
that order) with a subsequent signiﬁcant enhancement up
1.6- and 1.1-fold, respectively, at P5 and P6. On the other
hand, collagen type I expression presented its higher
value of expression, four-fold, at P3. With further cell ex-
pansion, collagen type I expression presented low values,
it being possible to perceive a statistically signiﬁcant con-
tinuous reduction tendency of expression until the end of
the study. Collagen type X and Runx2 relative expression
presented a similar trend. A signiﬁcant decrease from P3
to P4, followed by a slight increase at P5, was observed.
Cells cultured at P6 presented higher gene expression
values, but these were not statistically signiﬁcant. The
gene expression data suggest that hACs can be responsible
for a possible chondrogenic commitment of hWJSCs when
expanded in 2D monolayer surface. These results suggest
that co-culture with hACs provides anabolic soluble fac-
tors to hWJSCs towards the chondrogenic phenotype,
without the need to add exogenous growth factors. It
was not the aim of the present study to determine which
factors could lead to this commitment. Further research
should focus on the identiﬁcation of important factors
that might be responsible for driving stem cells into the
chondrogenic phenotype. Using different stem cell types,
Hwang et al. (2008) and Kim et al. (2007) suggested that
TGFβ and cytokine-like 1 (Cytl1) could modulate a
chondrogenic phenotype in human embryonic stem cells
and mesenchymal stem cells, respectively (Kim et al.,
2007). Cytl1 protein, oversecreted by chondrocytes,
showed the ability to promote the chondrogenic differen-
tiation of mesenchymal cells.
The use of chondrocytes collected and isolated from
the femoral condyles of patients undergoing partial knee
arthroplasty is a limitation of the current study. It is re-
markably difﬁcult to obtain healthy hACs for cartilage
research. However, knee arthropasties, commonly per-
formed worldwide, can provide relatively healthy carti-
lage tissue which, after digestion/isolation, allows a
source of primary adult articular chondrocytes to be ob-
tained for cartilage research and therapy. Our data show
that chondrocytes obtained from non-totally healthy car-
tilage biopsies could promote the chondrogenic differen-
tiation of hWJSCs by committing these cells to the
chondrogenic phenotype during 2D expansion.
Safranin O staining (Figure 5) showed the presence of
glycosaminoglycans, characteristic components of carti-
lage ECM or in cells exhibiting a chondrogenic phenotype,
due to a successful chrondrogenic differentiation process.
Figure 5A shows that, in expansion in monoculture condi-
tions, hWJSCs display a ﬁbroblast-like morphology, which
can be also observed in the external region of hWJSC
micromass pellets expanded in co-culture (P4–P6). Never-
theless, under this culture condition, aggregates of cells
with round shape and more positive safranin O staining
can be observed at the pellet core.
Immunohistochemical localization of collagen type I
and II in the micromass pellets maintained in culture for
3 weeks was performed to assess the chondrogenic phe-
notype level accomplished by hWJSCs expanded in
mono- and co-culture conditions. The presence of colla-
gen type I was detected in cells expanded in monoculture
(Figure 6A). From the beginning (P3), several positively
stained cellular regions were observed, demonstrating
incomplete/reduced chondrogenic differentiation of the
cells. After expansion under the co-culture condition,
micromass pellets of hWJSCs showed a minimal detection
of this protein.
Collagen type II is one of the main cartilage ECM pro-
teins. Under both conditions, hWJSCs were positive for
collagen type II. Differences could, however, be observed
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when cells were expanded under different conditions.
Looking in detail, several cell nodules with round shape,
stained positive for this cartilage ECM protein, were ob-
served in the micromass pellets made of hWJSCs ex-
panded in co-culture at all passages. This collagen type
II positive staining on the spherical cellular aggregates is
not observed in hWJSCs cultured alone, being markedly
weak within the pellet.
Collagen types I and II detection (Figure 6) corrobo-
rated the results of safranin O staining, showing greater
detection of cartilage ECM components in hWJSCs ex-
panded in co-culture with chrondrocytes compared to
those from hWJSCs cultured alone. Soluble factors re-
leased from hACs during co-culture may stimulate
hWJSCs to produce cartilage ECM components during
micromass pellet culture.
These results, in addition to the real-time RT–PCR
data showing positive modulation of collagens type I
and II, aggrecan, Sox9, COMP and TGFβ1, as well as
low values for collagen type X and Runx2, tend to sup-
port our initial hypothesis of the ability of chondrocytes
to secrete soluble active growth factors with a capacity
to inﬂuence hWJSCs phenotype in co-culture. In ascer-
taining which are the metabolic soluble factors and their
possible mechanisms of action on the chondrogenic com-
mitment of hWJSCs, the results of this study indicate the
potential of using stem cells and their co-culture with ar-
ticular chondrocytes to obtain cells in cartilage repair
strategies.
Conclusions
Our study suggests that in vitro expansion of hWJSCs in
monolayer and in a non-direct co-culture with human ar-
ticular chondrocytes can be used as a strategy to commit
a stem cell source to the chondrogenic phenotype. Al-
though promising results were obtained during in vitro
expansion and using the micromass pellet culturing
model, corroboration should be done in an in vivo envi-
ronment to demonstrate that the proposed hypothesis is
sufﬁcient to induce a stable phenotype.
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